Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma
Por um escritor misterioso
Descrição
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma
Neoadjuvant immunotherapy improves outlook in
Frontiers Factors Determining Long-Term Antitumor Responses to Immune Checkpoint Blockade Therapy in Melanoma
Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does it Matter?
Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma
Recent Advances in the Treatment of Melanoma
Adjuvant and Neoadjuvant Therapy in Melanoma - Rodabe N. Amaria, MD
A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma
ESMO22 Highlights on neoadj. vs adjuvant pembrolizumab in resected stage III-IV melanoma:SWOG S1801
Contemporary management of locoregionally advanced melanoma in Australia and New Zealand and the role of adjuvant systemic therapy - Smithers - 2021 - ANZ Journal of Surgery - Wiley Online Library
Cancers, Free Full-Text
Adjuvant Nivolumab or Ipilimumab + Nivolumab for Melanoma Determined by Pathological Response to a Single Dose of Neoadjuvant Nivolumab
Weighing the Pros and Cons of Neoadjuvant Anti–PD-1 Versus Neoadjuvant Combination Ipilimumab/Nivolumab in Melanoma
Immunotherapy in Melanoma: Highlights for the General Practitioner
Neoadjuvant-Adjuvant Pembrolizumab Better Than Adjuvant-Only in Melanoma
de
por adulto (o preço varia de acordo com o tamanho do grupo)
